Literature DB >> 9237595

Hibernating myocardium: clinical and functional response to revascularisation.

M G Gunning1, T P Chua, D Harrington, C J Knight, E Burman, D J Pennell, J Pepper, K Fox, S R Underwood.   

Abstract

OBJECTIVE: We assessed the effects of coronary bypass grafting on left ventricular (LV) function, exercise capacity and symptom profile in patients with LV impairment and evaluated the role of identifying myocardial hibernation in a prospective non-randomised study.
METHODS: Of 120 patients screened, 47 patients with LV ejection fraction < 35% and three vessel coronary artery disease were studied. All underwent stress/redistribution and separate day rest/redistribution T1-201 imaging together with cine MRI at enrolment, and cine MRI at follow-up. Group 1, 30 patients undergoing bypass surgery, underwent symptom limited treadmill exercise testing with peak VO2 measurement, and symptom profile evaluation less than 3 months before, and 3-6 months after operation. Revascularisation was assessed by post-operative T1-201 imaging and repeat coronary angiography. Group 2, 17 patients treated on medical therapy alone underwent symptom profile assessment at enrolment and follow-up for those who survived. Segmental hibernation was defined as the equivalent of greater than 50% of maximal T1-201 uptake where wall motion was severely impaired on resting imaging. Patients were considered to be hibernating where two of nine LV segments fulfilled these criteria.
RESULTS: In group 1, five patients died (17%), peri-or post-operatively, two defaulted and 23 attended follow-up studies. In group 2, three patients died prior to follow-up (18%). In the surgical group there was an increase in mean LVEF from 24.0 +/- 8% to 29.7 +/- 11% (P < 0.05) while in the medical group there was a fall from 25.7 +/- 10% to 20.6 +/- 8% (P < 0.05). In group 1, the mean NYHA dyspnoea grade improved from 2.7 to 1.4 while in the medical group it was unchanged, 2.6 to 2.5. In patients with myocardial hibernation identified pre-operatively, 18/19 (95%) improved LVEF after CABG compared with 2/4 (50%) of patients without hibernation. 17/19 (86%) patients with hibernation improved NYHA dyspnoea class compared with 2/4 (50%) of patients without. 60/93 (65%) of hibernating segments improved function after revascularisation while 47/53 (89%) hibernating segments showed no improvement on medical therapy alone.
CONCLUSION: In patients with severe LV impairment with myocardial hibernation, coronary artery bypass grafting improves both global and regional systolic LV function, and symptom profile. Medical treatment of patients with LV impairment and myocardial hibernation does not improve LV contractile function or symptoms. Both surgical and medical therapy carry a high mortality rate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237595     DOI: 10.1016/s1010-7940(97)01211-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

2.  Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation.

Authors:  R J Trent; G D Waiter; G S Hillis; F I McKiddie; T W Redpath; S Walton
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 3.  Reversible congestive heart failure caused by myocardial hibernation.

Authors:  J M Wilson
Journal:  Tex Heart Inst J       Date:  1999

4.  Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET.

Authors:  Christian Vahlhaus; Michael Schäfers; Hans-Jürgen Bruns; Frauke Janssen; Jörg Stypmann; Dieter Hammel; Hans H Scheld; Otmar Schober; Günter Breithardt; Thomas Wichter
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

5.  Assessment of myocardial viability in a porcine model of chronic coronary artery stenosis with dual dose dobutamine magnetic resonance imaging.

Authors:  S Dymarkowski; M Szilard; A Maes; X S Liu; Y M Huang; E Verbeken; L Mortelmans; J Bogaert; I De Scheerder
Journal:  Int J Cardiovasc Imaging       Date:  2003-02       Impact factor: 2.357

6.  Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent.

Authors:  F Fiocchi; F Sgura; A Di Girolamo; G Ligabue; S Ferraresi; R Rossi; R D'Amico; M G Modena; P Torricelli
Journal:  Radiol Med       Date:  2009-06-23       Impact factor: 3.469

Review 7.  Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure.

Authors:  Jeroen J Bax; Victoria Delgado
Journal:  J Nucl Cardiol       Date:  2015-03-03       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.